These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1851310)

  • 1. Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans.
    Lee MA; Nash JF; Barnes M; Meltzer HY
    Psychopharmacology (Berl); 1991; 103(2):258-64. PubMed ID: 1851310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors.
    Gartside SE; Cowen PJ
    Eur J Pharmacol; 1990 Apr; 179(1-2):103-9. PubMed ID: 2163847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man.
    Meltzer HY; Maes M
    Psychopharmacology (Berl); 1994 May; 114(4):635-43. PubMed ID: 7855226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-linked differences in cortisol, ACTH and prolactin responses to 5-hydroxy-tryptophan in healthy controls and minor and major depressed patients.
    Maes M; Vandewoude M; Schotte C; Maes L; Martin M; Blockx P
    Acta Psychiatr Scand; 1989 Dec; 80(6):584-90. PubMed ID: 2559587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of histaminergic and serotonergic neurons in the hypothalamic regulation of prolactin and ACTH secretion.
    Jørgensen H; Knigge U; Kjaer A; Warberg J
    Neuroendocrinology; 1996 Nov; 64(5):329-36. PubMed ID: 8930933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of serotonin 5-HT(1A) receptor antagonists on the secretion of corticotropin and prolactin.
    Jørgensen H; Kjaer A; Warberg J; Knigge U
    Neuroendocrinology; 2001 May; 73(5):322-33. PubMed ID: 11399905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ritanserin, a 5-HT2 receptor antagonist, does not modify ECT-induced prolactin release.
    Papakostas Y; Markianos M; Papadimitriou G; Stefanis C
    Psychopharmacology (Berl); 1990; 100(2):206-8. PubMed ID: 2106150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine responses to serotonergic agents in alcoholics.
    Lee MA; Meltzer HY
    Biol Psychiatry; 1991 Nov; 30(10):1017-30. PubMed ID: 1756196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder.
    Meltzer H; Bastani B; Jayathilake K; Maes M
    Neuropsychopharmacology; 1997 Jul; 17(1):1-11. PubMed ID: 9194044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ketanserin, a specific serotonin antagonist on the PRL, GH, ACTH and cortisol responses to hypoglycaemia in normal subjects.
    Prescott RW; Kendall-Taylor P; Weightman DR; Watson MJ; Ratcliffe WA
    Clin Endocrinol (Oxf); 1984 Feb; 20(2):137-42. PubMed ID: 6325044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ritanserin, a serotonin-S2 receptor antagonist, does not prevent 5-hydroxytryptophan-induced beta-EP, beta-LPH and cortisol secretion.
    Facchinetti F; Martignoni E; Nappi G; Marini S; Petraglia F; Sandrini G; Genazzani AR
    Horm Res; 1987; 27(1):42-6. PubMed ID: 2957299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketanserin without effects on basal anterior pituitary hormone secretion in healthy subjects.
    Gordin A; Mustajoki P; Pelkonen R
    J Endocrinol Invest; 1985 Feb; 8(1):73-5. PubMed ID: 2985688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-5-Hydroxytryptophan-induced flat body posture in the rat: antagonism by ritanserin and potentiation after 5,7-dihydroxytryptamine.
    Colpaert FC; Koek W; Lategan A
    Eur J Pharmacol; 1989 Oct; 169(1):175-8. PubMed ID: 2513211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
    Albinsson A; Palazidou E; Stephenson J; Andersson G
    Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan.
    Jørgensen H; Knigge U; Warberg J
    Neuroendocrinology; 1992 Mar; 55(3):336-43. PubMed ID: 1386914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study.
    Pitchot W; Wauthy J; Legros JJ; Ansseau M
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):151-5. PubMed ID: 15013031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 5-HT receptor subtype-selective drugs on locomotor activity and motor habituation in the DHT adult rat model.
    Pranzatelli MR; Jappay E; Snodgrass SR
    Pharmacol Biochem Behav; 1987 Jul; 27(3):497-504. PubMed ID: 3116560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa.
    Smarius LJ; Jacobs GE; Hoeberechts-Lefrandt DH; de Kam ML; van der Post JP; de Rijk R; van Pelt J; Schoemaker RC; Zitman FG; van Gerven JM; Gijsman HJ
    J Psychopharmacol; 2008 Jun; 22(4):426-33. PubMed ID: 18308795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men.
    Meltzer HY; Maes M
    Psychiatry Res; 1995 Sep; 58(2):89-98. PubMed ID: 8570772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.